Contrasting Affymetrix (AFFX) & Digiliti Money (DGLT)

Affymetrix (NASDAQ: AFFX) and Digiliti Money (OTCMKTS:DGLT) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, valuation and risk.


This table compares Affymetrix and Digiliti Money’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Affymetrix 4.24% 4.84% 2.97%
Digiliti Money -147.73% N/A -199.21%

Analyst Ratings

This is a breakdown of current ratings and price targets for Affymetrix and Digiliti Money, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Affymetrix 0 0 0 0 N/A
Digiliti Money 0 0 1 0 3.00

Digiliti Money has a consensus target price of $6.00, indicating a potential upside of 3,057.89%. Given Digiliti Money’s higher probable upside, analysts clearly believe Digiliti Money is more favorable than Affymetrix.

Earnings & Valuation

This table compares Affymetrix and Digiliti Money’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Affymetrix N/A N/A N/A $0.12 116.75
Digiliti Money $7.97 million 0.24 -$15.16 million ($6.05) -0.03

Affymetrix has higher earnings, but lower revenue than Digiliti Money. Digiliti Money is trading at a lower price-to-earnings ratio than Affymetrix, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

11.3% of Digiliti Money shares are owned by institutional investors. 50.9% of Digiliti Money shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.


Digiliti Money beats Affymetrix on 5 of the 9 factors compared between the two stocks.

About Affymetrix

Affymetrix, Inc. (Affymetrix) is a provider of life science products and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level. The Company operates through two business segments: Affymetrix Core and eBioscience. The Affymetrix Core segment focuses on the development, manufacture and commercialization of systems for genetic analysis in the life sciences, agricultural biotechnology (AgBio) and diagnostic industry. The eBioscience segment primarily focuses on the development, manufacture, marketing and distribution of research products in the areas of flow cytometry, immunoassays, microscopic imaging and other protein-based analyses. The Company sells its products to genomic research centers, academic institutions, government and private laboratories, as well as pharmaceutical, diagnostic and biotechnology companies. It maintains sales and distribution operations across the United States, Europe, Latin America and Asia.

About Digiliti Money

Digiliti Money Group, Inc., formerly Digiliti Money, Inc., is a technology solutions and services provider to the financial services industry. The Company’s solutions and services enable its clients, such as banks, credit unions and alternative financial services providers (AFS) to offer their customers remote deposit capture (RDC) and prepaid mobile money technologies and related services. It offers RDC products for businesses and consumers; mobile money management products for consumers, and training and support services for its financial services industry customers. The RDC products are offered to banks and credit unions in the United States, Canada and Latin America. Its mobile money management products are offered to traditional financial institutions (FIs), as well as AFS in the United States, Canada and Latin America. These FIs and AFS providers include banks, credit unions, prepaid card issuers, check cashers and payday lenders.

Receive News & Ratings for Affymetrix Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Affymetrix Inc. and related companies with's FREE daily email newsletter.

Leave a Reply